Inventor · disambiguated record
Rolf Jautelat
Also filed as: JAUTELAT ROLF
33 granted patents·12 pending applications·425 citations·filing 2001–2022
97Inventor score
Top patents by PatentIndex Score
45 records- 0197US8420656B2Substituted 5-fluoro-1H-pyrazolopyridines and their useFOLLMANN MARKUS·Filed 2011·Granted Apr 16, 2013·62 cites·7 claims
- 0296US9993476B2Substituted 5-flouro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Granted Jun 12, 2018·16 cites·13 claims
- 0396US8921377B2Substituted 5-fluoro-1H-pyrazolopyridines and their useBAYER IP GMBH·Filed 2013·Granted Dec 30, 2014·30 cites·12 claims
- 0495US11439642B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2020·Granted Sep 13, 2022·3 cites·66 claims
- 0594US9126998B2Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Sep 8, 2015·17 cites·15 claims
- 0694US7288547B2CDK-inhibitory 2-heteroaryl-pyrimidines, their production and use as pharmaceutical agentsSCHERING AG·Filed 2003·Granted Oct 30, 2007·54 cites·24 claims
- 0792US9309239B2Substituted 6-fluoro-1H-pyrazolo[4,3-b]pyridines and use thereofFOLLMANN MARKUS·Filed 2011·Granted Apr 12, 2016·9 cites·8 claims
- 0892US9266885B2Substituted 5-fluoro-1H-pyrazolopyridines and their useBAYER IP GMBH·Filed 2014·Granted Feb 23, 2016·11 cites·12 claims
- 0992US7235561B2Compound and a composition including such a compoundSCHERING AG·Filed 2002·Granted Jun 26, 2007·58 cites·58 claims
- 1090US8778964B2Hydroxy-substituted imidazo[1,2-a]-pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Jul 15, 2014·15 cites·6 claims
- 1189US10736896B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2018·Granted Aug 11, 2020·2 cites·7 claims
- 1289US7598260B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2007·Granted Oct 6, 2009·13 cites·79 claims
- 1388US8796305B2Carboxy-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Aug 5, 2014·14 cites·6 claims
- 1488US7750000B2Substituted imidazo[1,2b]pyridazines as kinase inhibitors, their preparation and use as medicamentsBAYER SCHERING PHARMA AG·Filed 2006·Granted Jul 6, 2010·24 cites·2 claims
- 1587US8946215B2Hydroxy-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Feb 3, 2015·10 cites·8 claims
- 1686US12064429B2Substituted 5-fluoro-1H-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2022·Granted Aug 20, 2024·0 cites·18 claims
- 1784US7338958B2Sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agentsSCHERING AG·Filed 2004·Granted Mar 4, 2008·19 cites·13 claims
- 1883US7943629B2Sulphimides as protein kinase inhibitorsBAYER SCHERING PHARMA AG·Filed 2007·Granted May 17, 2011·10 cites·24 claims
- 1982US7291624B2CDK-inhibitory pyrimidines, their production and use as pharmaceutical agentsBAYER SCHERING PHARMA AG·Filed 2004·Granted Nov 6, 2007·16 cites·90 claims
- 2081US8735412B2Sulfoximine-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as medicineLücking Ulrich·Filed 2009·Granted May 27, 2014·6 cites·19 claims
- 2180US9624214B2Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Granted Apr 18, 2017·3 cites·14 claims
- 2279US6844336B24-fluoroalkyl-2h-benzopyrans with anti-estogenic activitySCHERING AG·Filed 2001·Granted Jan 18, 2005·14 cites·36 claims
- 2378US8802686B2Sulfone-substituted anilinopyrimidine derivatives as CDK inhibitors, the production thereof, and use as a medicineLücking Ulrich·Filed 2009·Granted Aug 12, 2014·4 cites·12 claims
- 2477US7456191B2N-Aryl-sulfoximine-substituted pyrimidines as CDK-and/or VEGF inhibitors, their production and use as pharmaceutical agentsSCHERING AG·Filed 2006·Granted Nov 25, 2008·3 cites·27 claims
- 2575US9255100B2Substituted imidazopyridazinesKLAR ULRICH·Filed 2011·Granted Feb 9, 2016·3 cites·14 claims
- 2668US7018994B217α-ALKYL-17β-OXY-ESTRATRIENES AND INTERMEDIATE PRODUCTS FOR THEIR PRODUCTION, USE OF THE 17α-ALKYL-17β-OXY-ESTRATRIENES FOR THE PRODUCTION OF PHARMACEUTICAL AGENTS AS WELL AS PHARMACEUTICAL PREPARATIONSSCHERING AG·Filed 2002·Granted Mar 28, 2006·3 cites·28 claims
- 2766US10662185B2Amino-substituted imidazo[1,2-A] pyridinecarboxamides and their useBayer Pharma AG·Filed 2018·Granted May 26, 2020·0 cites·9 claims
- 2866US9199999B2Substituted imidazopyrazinesKLAR ULRICH·Filed 2011·Granted Dec 1, 2015·1 cites·5 claims
- 2965US9284317B2Substituted imidazo[1,2-a]pyrazines as MPS-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Mar 15, 2016·1 cites·10 claims
- 3065US9212184B26-thio-substituted imidazo[1,2-a]pyrazines as Mps-1 inhibitorsKOPPITZ MARCUS·Filed 2011·Granted Dec 15, 2015·1 cites·10 claims
- 3162US8507510B2Sulfoximine-substituted pyrimidines as CDK- and/or VEGF inhibitors, their production and use as pharmaceutical agentsLUECKING ULRICH·Filed 2004·Granted Aug 13, 2013·3 cites·20 claims
- 3260US2016129004A1Substituted 5-fluoro-1h-pyrazolopyridines and their useADVERIO PHARMA GMBH·Filed 2016·Application pending·0 cites
- 3359US2015274719A1Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2013·Application pending·0 cites
- 3456US10052312B2Amino-substituted imidazo[1,2-a]pyridinecarboxamides and their useBayer Pharma AG·Filed 2017·Granted Aug 21, 2018·0 cites·2 claims
- 3556US2016362408A1Aryl- and hetaryl-substituted imidazo[1,2-a]pyridine-3-carboxamides and use thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3651US7538100B217α-alkyl-17β-oxy-estratrienes and intermediate products for their production, use of the 17α-alkyl-17β-oxy-estratrienes for the production of pharmaceutical agents as well as pharmaceutical preparationsBAYER SCHERING PHARMA AG·Filed 2005·Granted May 26, 2009·0 cites·27 claims
- 3751US2008176866A1Novel hetaryl-phenylenediamine-pyrimidines as protein kinase inhibitorsJAUTELAT ROLF·Filed 2007·Application pending·0 cites
- 3846US2016176880A1Substituted imidazo[1,2-a]pyrazinecarboxamides and use thereofBayer Pharma AG·Filed 2014·Application pending·0 cites
- 3945US2008167330A1Carbamoylsulphoximides as protein kinase inhibitorsLUECKING ULRICH·Filed 2007·Application pending·0 cites
- 4042US2006111378A1Substituted 2-anilinopyrimidines as cell-cycle-kinase or receptor-tyrosine-kinase inhibitors, their production and use as pharmaceutical agentsCLEVE ARWED·Filed 2005·Application pending·0 cites
- 4140US2002107404A1Sulfur-containing indirubin derivatives, their production and useSCHERING AG·Filed 2001·Application pending·0 cites
- 4239US2002132792A1Aryl-substituted indirubin derivatives, their production and useSCHERING AG·Filed 2001·Application pending·0 cites
- 4339US2013303532A1Imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment hyperproliferative disordersKOPPITZ MARCUS·Filed 2011·Application pending·0 cites
- 4438US2014187548A16 substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disordersKOPPITZ MARCUS·Filed 2011·Application pending·0 cites
- 4538US2014135319A16-substituted imidazopyrazines for use as mps-1 and tkk inhibitors in the treatment of hyperproliferative disordersKOPPITZ MARCUS·Filed 2011·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Rolf Jautelat files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →